{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["20(7)"],"submitter":["Igoli J"],"pubmed_abstract":["<h4>Introduction</h4>Traumatic Brain Injury (TBI) is a leading cause of disability and death globally. It has a significant economic burden. Coagulopathy has been identified as one of the key factors contributing to the poor outcomes observed in TBI patients, and it has been theorised that the management of coagulopathy will improve patient outcomes. Low serum fibrinogen levels denote a coagulopathic state, and the therapeutic administration of fibrinogen has been proposed to correct this state. However, there is no consensus on its efficacy in patients with TBI. Hence, this systematic review and meta-analysis seeks to ascertain the prognostic value of serum fibrinogen levels in patients with TBI and assess the effect of fibrinogen administration on these patients.<h4>Methods</h4>Using the"],"journal":["PloS one"],"pagination":["e0310066"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12309985"],"repository":["biostudies-literature"],"pubmed_title":["Serum fibrinogen level and fibrinogen administration in patients with traumatic brain injury: A systematic review and meta-analysis protocol."],"pmcid":["PMC12309985"],"pubmed_authors":["Igoli J","Alao AE","Adebayo MA","Oyepitan TE","Olukoya O","Olaniyan A","Brabi D","Oludele H","Daniel JOI","Osunronbi T","Ogedegbe IS","Matthew D"],"additional_accession":[]},"is_claimable":false,"name":"Serum fibrinogen level and fibrinogen administration in patients with traumatic brain injury: A systematic review and meta-analysis protocol.","description":"<h4>Introduction</h4>Traumatic Brain Injury (TBI) is a leading cause of disability and death globally. It has a significant economic burden. Coagulopathy has been identified as one of the key factors contributing to the poor outcomes observed in TBI patients, and it has been theorised that the management of coagulopathy will improve patient outcomes. Low serum fibrinogen levels denote a coagulopathic state, and the therapeutic administration of fibrinogen has been proposed to correct this state. However, there is no consensus on its efficacy in patients with TBI. Hence, this systematic review and meta-analysis seeks to ascertain the prognostic value of serum fibrinogen levels in patients with TBI and assess the effect of fibrinogen administration on these patients.<h4>Methods</h4>Using the","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-03-31T10:36:02.718Z","creation":"2025-08-24T03:06:36.01Z"},"accession":"S-EPMC12309985","cross_references":{"pubmed":["40737252"],"doi":["10.1371/journal.pone.0310066"]}}